Computer-Aided Detection Market

The global computer-aided detection market is witnessing steady growth due to increasing adoption of artificial intelligence (AI) in medical imaging, rising demand for early disease detection, and growing investments in diagnostic technologies. The computer-aided detection market size was valued at USD 980.99 million in 2025 and is estimated to reach USD 1,538.62 million by 2034, growing at a CAGR of 5.17% during the forecast period (2026–2034).

Computer-aided detection (CAD) systems are advanced software solutions that assist radiologists and clinicians in identifying abnormalities within medical images. Initially developed to improve the detection of breast cancer in mammography, CAD technologies are now widely used across radiology, oncology, pulmonology, cardiology, and neurology. As healthcare providers increasingly prioritize AI-driven diagnostics, improved imaging accuracy, and early disease detection, computer-aided detection systems are becoming an essential component of modern medical imaging workflows.

For detailed market insights, growth forecasts, and competitive analysis, visit:

https://straitsresearch.com/report/computer-aided-detection-market

Artificial intelligence is transforming diagnostic imaging by improving image interpretation, reducing diagnostic errors, and supporting faster clinical decision-making. AI-powered CAD systems help radiologists detect subtle abnormalities that may otherwise be overlooked, improving diagnostic confidence and patient outcomes.

The rapid advancement of machine learning algorithms continues driving market growth.

Healthcare systems worldwide are placing greater emphasis on preventive care and early diagnosis of diseases such as breast cancer, lung cancer, colorectal cancer, and cardiovascular disorders. Computer-aided detection systems support early identification of suspicious lesions, enabling timely treatment and improved survival rates.

Growing screening programs continue accelerating CAD adoption.

Increasing investments in hospitals, diagnostic imaging centers, and healthcare infrastructure are expanding access to advanced imaging technologies. The integration of CAD software with MRI, CT, mammography, ultrasound, and X-ray systems is improving diagnostic efficiency across healthcare facilities.

Digital transformation in radiology continues strengthening market demand.

Deploying AI-powered CAD platforms requires significant investment in software, imaging infrastructure, integration, and staff training. Smaller healthcare facilities may face financial barriers when adopting advanced diagnostic technologies.

Cloud-based deployment models are helping reduce implementation costs.

Computer-aided detection systems must undergo rigorous clinical validation and regulatory approval before commercial deployment. Compliance with evolving healthcare regulations may increase development timelines and commercialization costs.

Continuous clinical research remains essential for successful market expansion.

The market is segmented into mammography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray. Mammography accounts for the largest market share due to the widespread use of CAD in breast cancer screening.

CT-based CAD solutions are expected to witness strong growth with increasing lung cancer screening programs.

Major applications include breast cancer detection, lung cancer detection, colorectal cancer screening, cardiovascular disease diagnosis, neurological disorders, and other diagnostic applications. Breast cancer detection remains the leading application owing to global screening initiatives and widespread mammography adoption.

AI-powered multi-organ diagnostic applications continue expanding rapidly.

The market serves hospitals, diagnostic imaging centers, specialty clinics, academic medical centers, and research institutions. Hospitals dominate the market due to increasing investments in advanced imaging technologies and AI-assisted diagnostics.

Diagnostic centers are also witnessing rapid CAD adoption to improve workflow efficiency.

North America dominates the computer-aided detection market due to advanced healthcare infrastructure, high adoption of AI technologies, strong reimbursement frameworks, and increasing cancer screening programs. The United States remains the largest regional market.

Europe represents a significant market supported by expanding medical imaging infrastructure, increasing healthcare digitization, and growing investments in artificial intelligence. Germany, the United Kingdom, France, Italy, and Spain remain key contributors.

Asia-Pacific is expected to witness the fastest growth during the forecast period. Rising healthcare expenditure, expanding diagnostic imaging services, increasing cancer incidence, and growing adoption of AI-powered healthcare solutions are driving demand across China, Japan, India, South Korea, and Southeast Asia.

Government initiatives supporting digital healthcare continue accelerating regional market growth.

These regions are gradually increasing adoption of AI-assisted diagnostic technologies through healthcare modernization, expanding imaging infrastructure, and improving access to early disease detection services. Continued healthcare investment is expected to create future market opportunities.

The computer-aided detection market is highly competitive, with leading companies focusing on artificial intelligence, deep learning algorithms, cloud-based imaging platforms, and workflow automation. Companies continue investing in research and development, strategic collaborations, and regulatory approvals to strengthen their competitive positions.

Advancements in generative AI, cloud computing, computer vision, and multi-modal imaging analytics are expected to shape the future of the computer-aided detection industry.

• GE HealthCare

• Siemens Healthineers AG

• Koninklijke Philips N.V.

• Fujifilm Holdings Corporation

• Canon Medical Systems Corporation

• Hologic, Inc.

• iCAD, Inc.

• Riverain Technologies

• ScreenPoint Medical

• Qure.ai Technologies Pvt. Ltd.

The global computer-aided detection market is expected to witness steady growth through 2034, driven by increasing adoption of AI in medical imaging, expanding disease screening programs, and rising demand for accurate and early diagnosis. Although implementation costs and regulatory requirements remain important challenges, continuous innovation in artificial intelligence, deep learning, and medical imaging technologies is expected to create substantial growth opportunities. As healthcare systems increasingly embrace AI-assisted diagnostics, computer-aided detection will continue to play a critical role in improving diagnostic accuracy and patient care.

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.

Email: sales@straitsresearch.com

Tel: 1 646 905 0080 (U.S.)

Tel: 44 203 695 0070 (U.K.)